Tarpeyo Capsule, Delayed Release
Product Images NDC 81749-004

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Tarpeyo (NDC 81749-004). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Calliditas Therapeutics Ab, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Tar02 0001 01)

Chemical structure diagram of budesonide, the active ingredient in Tarpeyo 4 mg delayed-release oral capsules. The diagram illustrates the molecular framework and arrangement of the compound's atoms and bonds.*

FDA Label Image

Principal Display Panel (4 mg Bottle Label)

Label for Tarpeyo (budesonide) delayed release capsules, 4 mg strength. The label shows the product name, dosage form, strength, and quantity (120 capsules). It includes the NDC 81749-004-01 and is manufactured and distributed by Calliditas Therapeutics AB. Storage instructions and trademark information are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.